论文部分内容阅读
目的对应用奥曲肽与生长抑素对患有肝硬化上消化道出血的患者进行治疗的临床效果进行比较分析。方法抽取86例患有肝硬化上消化道出血的临床确诊患者病例,将其分为A、B两组,平均每组43例。A组患者生长抑素进行治疗;B组患者采用奥曲肽进行治疗。结果 B组患者治疗后的症状改善情况明显优于A组患者;该组患者治疗结束后病情复发率明显低于A组患者;两组患者治疗过程中,没有出现任何不良反应。结论应用奥曲肽对患有肝硬化上消化道出血的患者进行治疗的临床效果非常明显。
Objective To compare the clinical effects of octreotide and somatostatin on patients with cirrhosis and upper gastrointestinal bleeding. Methods Totally 86 cases of clinically diagnosed patients with upper gastrointestinal hemorrhage were divided into A and B groups, with an average of 43 cases in each group. Patients in group A were treated with somatostatin and patients in group B were treated with octreotide. Results The improvement of symptoms after treatment in group B was better than that in group A; the recurrence rate of the patients in group B after treatment was significantly lower than that in group A; no adverse reactions occurred in the two groups during treatment. Conclusion The application of octreotide in patients with cirrhosis of upper gastrointestinal bleeding for the treatment of clinical effect is very obvious.